Valuation: Hologic, Inc.

Market Cap 16.97B 14.83B 13.68B 12.61B 23.77B 1,634B 24.3B 164B 64.33B 800B 63.73B 62.33B 2,755B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 15.2B 14.02B 12.93B 24.36B 1,675B 24.9B 168B 65.93B 820B 65.31B 63.87B 2,823B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
6 months+1.37%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 63.19
Extreme 63.1923
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 06/04/2026
Director of Finance/CFO - 15/04/2026
Chief Operating Officer 46 31/12/2023
Director TitleAgeSince
Director/Board Member 63 06/04/2026
Date Insider Type Main position Quantity % Market Cap.
07/04/26 Issuer sale

President, Breast & Skeletal

59,146 0.0265%
07/04/26 Issuer sale

Director

10,103 0.0045%
07/04/26 Issuer sale

Director

103,367 0.0463%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+18.73%-3.74% 16.97B
-1.97%+1.03%+25.30%+1.37% 198B
-0.58%+2.40%+4.64%-14.27% 144B
-14.15%-15.08%-33.08%-2.38% 122B
-1.32%-1.65%-57.93%-16.31% 65.44B
-2.40%-7.03%+12.54%-7.47% 49.36B
-0.11%+1.53%-24.62%-31.81% 44.75B
-3.41%-2.11%+12.98%+11.17% 37.13B
-2.44%-1.98%+24.27%+36.75% 36.23B
-4.00%-2.52%-17.27%-22.32% 28.69B
Average -1.51%-2.00%-3.45%-4.90% 74.31B
Weighted average by Cap. -1.29%-1.77%-1.97%-5.24%

Financials

2024 2025
Net sales 4.03B 3.52B 3.25B 3B 5.65B 388B 5.77B 38.85B 15.28B 190B 15.14B 14.8B 654B 4.1B 3.58B 3.31B 3.05B 5.74B 395B 5.87B 39.52B 15.55B 193B 15.4B 15.06B 666B
Net income 790M 690M 637M 587M 1.11B 76.03B 1.13B 7.61B 2.99B 37.24B 2.96B 2.9B 128B 566M 494M 456M 420M 793M 54.48B 810M 5.45B 2.14B 26.68B 2.12B 2.08B 91.85B
Net Debt 321M 281M 259M 239M 450M 30.94B 460M 3.1B 1.22B 15.15B 1.21B 1.18B 52.17B 421M 368M 339M 313M 590M 40.53B 603M 4.06B 1.6B 19.85B 1.58B 1.55B 68.34B
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. HOLX Stock